Jelveh Lameh

Jelveh Lameh, Ph.D. has over 30 years of experience in both academia and the biotech/pharmaceutical industry, holding various leadership roles. In academia, she served as an Assistant Professor at the University of California, San Francisco (UCSF), and as Head of In Vitro Pharmacology at MRI, where she led teams in neuropharmacology, drug discovery, and receptor pharmacology. She also served as the Principal Investigator (PI) on several NIH grants.
At biotech/ pharmaceutical industry, Dr. Lameh has held various leadership positions including Head of BioPharma Laboratory, Head of Operations and Regulatory Affairs, Chief Information Officer, VP of Regulatory & Quality Compliance, and Head of Translational Research. Dr. Lameh has led the development and implementation of hundreds of novel cancer diagnostic assays for clinical trials and as PI or Co-PI, contributed to the validation of several companion diagnostics.
Dr. Lameh has authored over 50 peer-reviewed articles and possesses expertise in biomarker discovery & development, in vitro diagnostics, companion diagnostics, drug development, molecular pharmacology, and cell signaling.
Dr. Lameh earned her Ph.D. in Pharmacology & Toxicology from the University of California, Davis, and completed her postdoctoral training at UC San Francisco.